Mattias Sandström
Mattias Sandström
PhD, Uppsala Universitet
Verified email at akademiska.se - Homepage
Title
Cited by
Cited by
Year
Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule
V Tolmachev, A Orlova, R Pehrson, J Galli, B Baastrup, K Andersson, ...
Cancer research 67 (6), 2773-2782, 2007
2402007
Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors
A Orlova, V Tolmachev, R Pehrson, M Lindborg, T Tran, M Sandström, ...
Cancer research 67 (5), 2178-2186, 2007
2212007
Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment
M Sandström, U Garske-Román, D Granberg, S Johansson, C Widström, ...
Journal of Nuclear Medicine 54 (1), 33-41, 2013
1912013
First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule
J Sörensen, D Sandberg, M Sandström, A Wennborg, J Feldwisch, ...
Journal of nuclear medicine 55 (5), 730-735, 2014
1892014
Individualized dosimetry in patients undergoing therapy with 177 Lu-DOTA-D-Phe 1-Tyr 3-octreotate
M Sandström, U Garske, D Granberg, A Sundin, H Lundqvist
European journal of nuclear medicine and molecular imaging 37 (2), 212-225, 2010
1522010
Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse
JB Borges, F Suarez-Sipmann, SH Bohm, G Tusman, A Melo, E Maripuu, ...
Journal of applied physiology 112 (1), 225-236, 2012
1402012
Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse
JB Borges, F Suarez-Sipmann, SH Bohm, G Tusman, A Melo, E Maripuu, ...
Journal of applied physiology 112 (1), 225-236, 2012
1402012
Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry
V Tolmachev, M Friedman, M Sandström, TLJ Eriksson, D Rosik, M Hodik, ...
Journal of Nuclear Medicine 50 (2), 274-283, 2009
1352009
Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE
E Ilan, M Sandström, C Wassberg, A Sundin, U Garske–Román, ...
Journal of nuclear medicine 56 (2), 177-182, 2015
1322015
Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification
I Velikyan, A Sundin, J Sörensen, M Lubberink, M Sandström, ...
Journal of Nuclear Medicine 55 (2), 204-210, 2014
1302014
Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111 In-DOTA-Z EGFR: 2377 Affibody molecule: aspect of the injected tracer amount
V Tolmachev, D Rosik, H Wållberg, A Sjöberg, M Sandström, M Hansson, ...
European journal of nuclear medicine and molecular imaging 37 (3), 613-622, 2010
1292010
Measuring HER2-receptor expression in metastatic breast cancer using [68Ga] ABY-025 Affibody PET/CT
J Sörensen, I Velikyan, D Sandberg, A Wennborg, J Feldwisch, ...
Theranostics 6 (2), 262, 2016
1262016
99mTc-maEEE-ZHER2:342, an Affibody Molecule-Based Tracer for the Detection of HER2 Expression in Malignant Tumors
T Tran, T Engfeldt, A Orlova, M Sandström, J Feldwisch, L Abrahmsén, ...
Bioconjugate chemistry 18 (6), 1956-1964, 2007
1252007
Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules
S Ahlgren, A Orlova, D Rosik, M Sandström, A Sjöberg, B Baastrup, ...
Bioconjugate chemistry 19 (1), 235-243, 2008
1232008
Comparative biodistribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors
M Sandström, I Velikyan, U Garske-Román, J Sörensen, B Eriksson, ...
Journal of Nuclear Medicine 54 (10), 1755-1759, 2013
1122013
Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffold
S Ahlgren, A Orlova, H Wållberg, M Hansson, M Sandström, R Lewsley, ...
Journal of nuclear medicine 51 (7), 1131-1138, 2010
1062010
Prospective observational study of 177 Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a …
U Garske-Román, M Sandström, KF Baron, L Lundin, P Hellman, S Welin, ...
European journal of nuclear medicine and molecular imaging 45 (6), 970-988, 2018
1032018
Busulphan kinetics and limited sampling model in children with leukemia and inherited disorders.
M Hassan, A Fasth, B Gerritsen, A Haraldsson, Z Syrůcková, ...
Bone marrow transplantation 18 (5), 843-850, 1996
1021996
A HER2-binding Affibody molecule labelled with 68 Ga for PET imaging: direct in vivo comparison with the 111 In-labelled analogue
V Tolmachev, I Velikyan, M Sandström, A Orlova
European journal of nuclear medicine and molecular imaging 37 (7), 1356-1367, 2010
962010
Population analysis of the pharmacokinetics and the haematological toxicity of the fluorouracil-epirubicin-cyclophosphamide regimen in breast cancer patients
M Sandström, H Lindman, P Nygren, M Johansson, J Bergh, MO Karlsson
Cancer chemotherapy and pharmacology 58 (2), 143, 2006
872006
The system can't perform the operation now. Try again later.
Articles 1–20